Jeena Sikho Lifecare publishes 13 medical case studies in journals

Jeena Sikho Lifecare Limited has published 13 case studies and case reports in medical journals, authored by its Managing Director, senior consultants, and Ayurvedic experts. The publications, dated May 25, 2026, demonstrate the company's commitment to Ayurvedic research and evidence-based clinical practice. The studies cover the management of complex conditions including Chronic Kidney Disease (CKD), liver cirrhosis, and gastrointestinal tumors using Ayurvedic interventions.

The disclosures were made to the National Stock Exchange of India Limited and BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The articles appear in journals such as the International Journal of Ayurveda and Herbal Research (IJAHR), Journal of Ayurveda and Integrated Medical Sciences (JAIMS), and Ayurvediya Adhyayan: Global Journal of Ayurveda, Yoga and Integrative Medicine.

The table below details the specific case studies and reports published:

S. No.	Type	Name	Link
1.	Case Study	Ayurvedic Management Of Uchcharaktachap: A Clinical Case And Therapeutic Insights	https://ahr.a2zjournals.com/index.php/ahr/article/view/147
2.	Case Study	Arbuda with Yakrit Ashrita Roga: An Ayurvedic Case Study on Gastrointestinal Stromal Tumor with Liver Metastasis	https://ahr.a2zjournals.com/index.php/ahr/article/view/152/105
3.	Case Report	Management of Vrikka Vikara (CKD) and Raktagata Vata (HTN): A Case Report	https://ahr.a2zjournals.com/index.php/ahr/article/view/148/101
4.	Case Study	A Comprehensive Review of Ayurvedic Interventions in the Management of Chronic Kidney Disease: A Case Study	https://ahr.a2zjournals.com/index.php/ahr/article/view/150/103
5.	Case Study	Management of Vrikka vikara (Chronic Kidney Disease) Through Ayurveda: A Holistic Approach	https://ahr.a2zjournals.com/index.php/ahr/article/view/149
6.	Case Report	Integrated Ayurvedic Management of Chronic Kidney Disease, Hypertension, and Diabetes: A Case Report	https://ahr.a2zjournals.com/index.php/ahr/article/view/151/104
7.	Case Study	Ayurveda-Based Integrative Therapeutics for Vandhyatva (Female Infertility): A Clinical Case Study	https://jaims.in/jaims/article/view/6516
8.	Case Study	Clinical Management of Beej Granthi (Ovarian Cyst) through Nidan Parivarjana, Ahar-Vihar Regulation, and Shamana Chikitsa: A Case Study	https://jaims.in/jaims/article/view/6519
9.	Case Study	Management of Stana Granthi (Fibroadenosis) through Kapha-Vata Shamana and Amapachana: A Case Study	https://jaims.in/jaims/article/view/6520
10.	Case Study	Kumbha Kamala: An Ayurvedic Approach to Liver Cirrhosis Management – A Case Study	https://www.vedadhyan.com/media/post/AYUR-2-3-2.1.pdf
11.	Case Study	Madyapan Janita-Yakrit-Rogah: A Case Study on Ayurvedic Management	https://www.vedadhyan.com/media/post/AYUR-2-3-3.1.pdf
12.	Case Study	Vrikk Vyadhi Chikitsa: An Ayurvedic Case Study on Complete Management of Chronic Kidney Disease	https://www.vedadhyan.com/media/post/AYUR-2-3-5.1.pdf
13.	Case Study	A Case Study on the Ayurvedic Management of End-Stage CKD with Type II Diabetes Mellitus and Hypertension: Restoring Balance and Health	https://www.vedadhyan.com/media/post/AYUR-2-3-4.1.pdf

The information is available on the company's website. Manish Grover, Managing Director, signed the disclosure on May 25, 2026.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-5.84%	+4.09%	-3.41%	-6.28%	-71.04%	+276.06%

Jeena Sikho Lifecare Limited has confirmed that no encumbrance has been created on the shares held by its promoters during the financial year ended March 31, 2026. This disclosure was made in accordance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The declaration was submitted by Manish Grover, Promoter and Managing Director, on behalf of the promoter group and Persons Acting in Concert (PAC).

The company stated that neither the promoters nor the PAC members have pledged any shares directly or indirectly during the specified period. The declaration serves to inform the stock exchanges and shareholders regarding the status of the promoter holdings. The detailed shareholding pattern and pledge status were provided in an annexure to the declaration.

Shareholding Details

The disclosure outlines the shareholding of various promoters and members of the promoter group as of March 31, 2026. The table below details the number of shares held by each entity, their percentage of total diluted shares or voting capital, and the number of shares pledged.

S. No.	Name	Category	Shares	% of total diluted shares/voting capital of the TC	Number of shares pledge
1	Manish Grover	Promoter	78641190	63.27%	NIL
2	Bhavna Grover	Promoter	243000	0.20%	NIL
3	Rohit Grover	Promoter Group	76191	0.06 %	NIL
4	Mukesh Grover	Promoter Group	52740	0.04 %	NIL
5	Santosh Grover	Promoter Group	30461	0.02 %	NIL
6	Sahil Jain	Promoter Group	17191	0.01%	NIL
7	Shreya Grover	Promoter Group	8190	0.01%	NIL
8	Akansha Jain	Promoter Group	8190	0.01%	NIL
9	Ashish Grover	Promoter Group	3495	0	NIL
10	Madhav Grover	Promoter Group	0	0	NIL
11	Sunil Khurana	Promoter Group	0	0	NIL
12	Som Khurana	Promoter Group	0	0	NIL
13	Premkanta Kapoor	Promoter Group	0	0	NIL
14	Sunita Uppal	Promoter Group	0	0	NIL
15	Shweta Grover	Promoter Group	9450	0	NIL
16	Meetu Grover	Promoter Group	18115	0.01%	NIL
17	Dheeraj Grover	Promoter Group	690	0	NIL
18	Anju Khurana	Promoter Group	682	0	NIL
19	Shweta Aggarwal	Promoter Group	5125	0	NIL
20	Vishal Aggarwal	Promoter Group	12430	0	NIL
21	Vandana Takkar	Promoter Group	935	0	NIL
22	Rajesh Grover	Promoter Group	113	0	NIL
23	Anshika Grover	Promoter Group	450	0	NIL
24	Jeena Green Resources Private Limited	PAC	NIL	NIL	NIL
25	Jeena Sikho International LLC	PAC	NIL	NIL	NIL
26	Back to Roots Ayurveda by Dr. Shyam LLC	PAC	NIL	NIL	NIL

Status of PAC Holdings

The declaration also included details regarding Persons Acting in Concert (PAC) with the promoters. Three entities were listed under the PAC category: Jeena Green Resources Private Limited, Jeena Sikho International LLC, and Back to Roots Ayurveda by Dr. Shyam LLC. The disclosure indicates that these entities hold NIL shares and have NIL shares pledged. The confirmation was signed and submitted to the National Stock Exchange of India Limited and BSE Limited on April 4, 2026.